SuperworthInfuSystem EPS INFU
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $0.41
- Latest quarter, Q2 FY26
- $0.15
- +25% on a year earlier
- Fiscal year 2025
- $0.32
- +220% on the year before
InfuSystem's earnings per share was $0.41 over the twelve months to Jun 30, 2026, up 78% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.15, up 25% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 17% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.32 | +220% |
| FY2024 | $0.10 | +233% |
| FY2023 | $0.03 | n/a |
| FY2022 | −$0.01 | −114% |
| FY2021 | $0.07 | −91% |
| FY2020 | $0.80 | +1233% |
| FY2019 | $0.06 | n/a |
| FY2018 | −$0.05 | n/a |
| FY2017 | −$0.92 | n/a |
| FY2016 | −$0.01 | −108% |
| FY2015 | $0.13 | −13% |
| FY2014 | $0.15 | +114% |
| FY2013 | $0.07 | n/a |
| FY2012 | −$0.07 | n/a |
| FY2011 | −$2.16 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.15 | +25% | $0.41 | |
| Q1 FY26 | $0.05 | n/a | $0.38 | |
| Q4 FY25 | $0.10 | +150% | $0.32 | |
| Q3 FY25 | $0.11 | +38% | $0.26 | |
| Q2 FY25 | $0.12 | +300% | $0.23 | |
| Q1 FY25 | −$0.01 | n/a | $0.14 | |
| Q4 FY24 | $0.04 | n/a | $0.10 | |
| Q3 FY24 | $0.08 | +167% | $0.06 | |
| Q2 FY24 | $0.03 | +50% | $0.01 | |
| Q1 FY24 | −$0.05 | n/a | $0.00 | |
| Q4 FY23 | $0.00 | n/a | $0.03 | |
| Q3 FY23 | $0.03 | +50% | $0.03 |
Against its peers
Companies in Medical - Instruments & Supplies nearest InfuSystem's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| INFUInfuSystem | $0.41 | +78% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| MOVMovado | $1.80 | +137% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| BVSBioventus | $0.77 | |
| Peer median | $1.63 |
Where InfuSystem ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on InfuSystem
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.